AfoliOpen Afoli →

Ivabradine

Ivabradine is an approved active ingredient.

Open in Afoli Medicines →

Medication used for the symptomatic management of stable heart related chest pain and heart failure not fully managed by beta blockers

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

1. INDICATIONS AND USAGE Corlanor (ivabradine) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated: To reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular…

US label

Symptomatic treatment of chronic stable angina pectoris Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ? 70 bpm.

EMA

How it works

Common side effects

6. ADVERSE REACTIONS Clinically significant adverse reactions that appear in other sections of the labeling include: Atrial Fibrillation Bradycardia and Conduction Disturbances Most common adverse reactions occurring in ≥ 1% of patients are bradycardia, hypertension, atrial fibrillation and luminous phenomena…

US label

Who should not take it

4. CONTRAINDICATIONS Corlanor is contraindicated in patients with: • Acute decompensated heart failure • Clinically significant hypotension • Sick sinus syndrome, sinoatrial block or 3 rd degree AV block, unless a functioning demand pacemaker is present •…

US label

Pregnancy and breastfeeding

Based on findings in animals, Corlanor may cause fetal harm when administered to a pregnant woman. There are no adequate and well-controlled studies of Corlanor in pregnant women to inform any drug-associated risks.

Excerpts from the US prescribing label (public domain), copied without changes.

Interactions

Recorded interactions from open sources (Wikidata, US labels). The list is not complete — ask a pharmacist.

Brand names

United States

Corlanor

European Union

Ivabradine Accord · Ivabradine Anpharm · Ivabradine Zentiva · Procoralan

Canada

Lancora

Other trade names

Ivabradine jensonr

Approval status

US Food and Drug Administration
prescription · since 2015
European Medicines Agency
authorised · since 2005
Health Canada
prescription · marketed
First approval anywhere
2005

Codes

ATC
C01EB17
RxNorm CUI
1649480
ChEMBL
CHEMBL471737
PubChem CID
132999
UNII
3H48L0LPZQ
Wikidata
Q425729

Frequently asked questions

What is Ivabradine used for?

Ivabradine is used for: Congestive heart failure, Cardiomyopathy, Heart failure, Cardiovascular disease, and Angina pectoris.

What are the brand names of Ivabradine?

Brand names of Ivabradine include Corlanor, Ivabradine Accord, Ivabradine Anpharm, Ivabradine Zentiva, Procoralan, Lancora, and Ivabradine jensonr.

Medicines in the same class

Sources and licences

Updated November 15, 2026